CLPTM1L: Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS (v475))
 
imported>OAbot
m (Open access bot: add pmc identifier to citation with #oabot.)
 
Line 1: Line 1:
{{Infobox_gene}}
{{Infobox_gene}}
'''Cleft lip and palate transmembrane protein 1-like protein''' (CLPTM1-like protein), also known as '''cisplatin resistance-related protein 9''' (CRR9p), is a [[protein]] that in humans is encoded by the ''CLPTM1L'' [[gene]].<ref name="entrez">{{cite web |title=Entrez Gene: CLPTM1-like |url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=81037 |accessdate=}}</ref><ref name="Yamamoto-2001">{{cite journal |vauthors=Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y |title=A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. |journal=Biochem Biophys Res Commun |volume=280 |issue=4 |pages=1148–54 |date=Feb 2001 |pmid=11162647 |doi=10.1006/bbrc.2001.4250}}</ref> CRR9p is associated with [[cisplatin]]-induced [[apoptosis]].<ref name="Yamamoto-2001"/> CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.<ref>{{cite journal |vauthors=James MA, Wen W, Wang Y, Byers LA, Heymach JV, Coombes KR, Girard L, Minna J, You M |title=Functional Characterization of CLPTM1L as a Lung |journal=PLoS ONE |volume=7 |issue=6 |pages=63116 |year=2012 |pmid=22675468 |pmc=3366984 |doi=10.1371/journal.pone.0036116}}</ref> Inhibition of CLPTM1L has been shown to inhibit oncogenic transformation and tumorigenesis caused by the KRas oncogene partially through the PI3K/Akt survival signaling axis.<ref>{{cite journal |vauthors=James MA, Vikis HG, Tate E, Rymaszewski AL, et al. |title=CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. |journal=Can Res |volume=74 |issue=4 |pages=1116–27 |year=2014 |pmid=24366883 |doi=10.1158/0008-5472.CAN-13-1617}}</ref>
'''Cleft lip and palate transmembrane protein 1-like protein''' (CLPTM1-like protein), also known as '''cisplatin resistance-related protein 9''' (CRR9p), is a [[protein]] that in humans is encoded by the ''CLPTM1L'' [[gene]].<ref name="entrez">{{cite web |title=Entrez Gene: CLPTM1-like |url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=81037 |accessdate=}}</ref><ref name="Yamamoto-2001">{{cite journal |vauthors=Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y |title=A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. |journal=Biochem Biophys Res Commun |volume=280 |issue=4 |pages=1148–54 |date=Feb 2001 |pmid=11162647 |doi=10.1006/bbrc.2001.4250}}</ref> CRR9p is associated with [[cisplatin]]-induced [[apoptosis]].<ref name="Yamamoto-2001"/> CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.<ref>{{cite journal |vauthors=James MA, Wen W, Wang Y, Byers LA, Heymach JV, Coombes KR, Girard L, Minna J, You M |title=Functional Characterization of CLPTM1L as a Lung |journal=PLoS ONE |volume=7 |issue=6 |pages=63116 |year=2012 |pmid=22675468 |pmc=3366984 |doi=10.1371/journal.pone.0036116}}</ref> Inhibition of CLPTM1L has been shown to inhibit oncogenic transformation and tumorigenesis caused by the KRas oncogene partially through the PI3K/Akt survival signaling axis.<ref>{{cite journal |vauthors=James MA, Vikis HG, Tate E, Rymaszewski AL, et al. |title=CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. |journal=Cancer Res |volume=74 |issue=4 |pages=1116–27 |year=2014 |pmid=24366883 |doi=10.1158/0008-5472.CAN-13-1617}}</ref>


== See also ==
== See also ==
Line 24: Line 24:
* {{cite journal |vauthors=Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, DeKosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrièze F, Dartigues JF, Tzourio C, Buée L, Pasquier F, Berr C, Mann D, Lendon C, Alpérovitch A, Kamboh MI, Amouyel P, Lambert JC |title=Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. |journal=Mol. Psychiatry |volume=14 |issue=11 |pages=1004–16 |year=2009 |pmid=19204726 |pmc=2860783 |doi=10.1038/mp.2009.10}}
* {{cite journal |vauthors=Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, DeKosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrièze F, Dartigues JF, Tzourio C, Buée L, Pasquier F, Berr C, Mann D, Lendon C, Alpérovitch A, Kamboh MI, Amouyel P, Lambert JC |title=Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. |journal=Mol. Psychiatry |volume=14 |issue=11 |pages=1004–16 |year=2009 |pmid=19204726 |pmc=2860783 |doi=10.1038/mp.2009.10}}
* {{cite journal |vauthors=Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, Sigurdsson A, Gudbjartsson DF, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Scherer D, Hemminki K, Rudnai P, Gurzau E, Koppova K, Botella-Estrada R, Soriano V, Juberias P, Saez B, Gilaberte Y, Fuentelsaz V, Corredera C, Grasa M, Höiom V, Lindblom A, Bonenkamp JJ, van Rossum MM, Aben KK, de Vries E, Santinami M, Di Mauro MG, Maurichi A, Wendt J, Hochleitner P, Pehamberger H, Gudmundsson J, Magnusdottir DN, Gretarsdottir S, Holm H, Steinthorsdottir V, Frigge ML, Blondal T, Saemundsdottir J, Bjarnason H, Kristjansson K, Bjornsdottir G, Okamoto I, Rivoltini L, Rodolfo M, Kiemeney LA, Hansson J, Nagore E, Mayordomo JI, Kumar R, Karagas MR, Nelson HH, Gulcher JR, Rafnar T, Thorsteinsdottir U, Olafsson JH, Kong A, Stefansson K |title=New common variants affecting susceptibility to basal cell carcinoma. |journal=Nat. Genet. |volume=41 |issue=8 |pages=909–14 |year=2009 |pmid=19578363 |pmc=2973331 |doi=10.1038/ng.412}}
* {{cite journal |vauthors=Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, Sigurdsson A, Gudbjartsson DF, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Scherer D, Hemminki K, Rudnai P, Gurzau E, Koppova K, Botella-Estrada R, Soriano V, Juberias P, Saez B, Gilaberte Y, Fuentelsaz V, Corredera C, Grasa M, Höiom V, Lindblom A, Bonenkamp JJ, van Rossum MM, Aben KK, de Vries E, Santinami M, Di Mauro MG, Maurichi A, Wendt J, Hochleitner P, Pehamberger H, Gudmundsson J, Magnusdottir DN, Gretarsdottir S, Holm H, Steinthorsdottir V, Frigge ML, Blondal T, Saemundsdottir J, Bjarnason H, Kristjansson K, Bjornsdottir G, Okamoto I, Rivoltini L, Rodolfo M, Kiemeney LA, Hansson J, Nagore E, Mayordomo JI, Kumar R, Karagas MR, Nelson HH, Gulcher JR, Rafnar T, Thorsteinsdottir U, Olafsson JH, Kong A, Stefansson K |title=New common variants affecting susceptibility to basal cell carcinoma. |journal=Nat. Genet. |volume=41 |issue=8 |pages=909–14 |year=2009 |pmid=19578363 |pmc=2973331 |doi=10.1038/ng.412}}
* {{cite journal |vauthors=Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, Huddart RA, Bishop DT, Easton DF, Stratton MR, Rahman N |title=Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. |journal=Nat. Genet. |volume=42 |issue=7 |pages=604–7 |year=2010 |pmid=20543847 |doi=10.1038/ng.607}}
* {{cite journal |vauthors=Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, Huddart RA, Bishop DT, Easton DF, Stratton MR, Rahman N |title=Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. |journal=Nat. Genet. |volume=42 |issue=7 |pages=604–7 |year=2010 |pmid=20543847 |doi=10.1038/ng.607|pmc=3773909 }}
* {{cite journal |vauthors=Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Metsapalu A, Vooder T, Nelis M, Välk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeböller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE |title=A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. |journal=Am. J. Hum. Genet. |volume=85 |issue=5 |pages=679–91 |year=2009 |pmid=19836008 |pmc=2775843 |doi=10.1016/j.ajhg.2009.09.012}}
* {{cite journal |vauthors=Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Metsapalu A, Vooder T, Nelis M, Välk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeböller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE |title=A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. |journal=Am. J. Hum. Genet. |volume=85 |issue=5 |pages=679–91 |year=2009 |pmid=19836008 |pmc=2775843 |doi=10.1016/j.ajhg.2009.09.012}}
{{refend}}
{{refend}}

Latest revision as of 09:33, 16 May 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein), also known as cisplatin resistance-related protein 9 (CRR9p), is a protein that in humans is encoded by the CLPTM1L gene.[1][2] CRR9p is associated with cisplatin-induced apoptosis.[2] CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.[3] Inhibition of CLPTM1L has been shown to inhibit oncogenic transformation and tumorigenesis caused by the KRas oncogene partially through the PI3K/Akt survival signaling axis.[4]

See also

References

  1. "Entrez Gene: CLPTM1-like".
  2. 2.0 2.1 Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y (Feb 2001). "A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis". Biochem Biophys Res Commun. 280 (4): 1148–54. doi:10.1006/bbrc.2001.4250. PMID 11162647.
  3. James MA, Wen W, Wang Y, Byers LA, Heymach JV, Coombes KR, Girard L, Minna J, You M (2012). "Functional Characterization of CLPTM1L as a Lung". PLoS ONE. 7 (6): 63116. doi:10.1371/journal.pone.0036116. PMC 3366984. PMID 22675468.
  4. James MA, Vikis HG, Tate E, Rymaszewski AL, et al. (2014). "CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis". Cancer Res. 74 (4): 1116–27. doi:10.1158/0008-5472.CAN-13-1617. PMID 24366883.

External links

Further reading